Immune imprinting: The crux of waning COVID-19 booster effectiveness against new variants

The study in Nature Microbiology reviews the concept of immune imprinting and its influence on antibody responses to SARS-CoV-2, highlighting challenges for COVID-19 booster vaccination efficacy against emerging variants. Researchers suggest that understanding immune imprinting is crucial for developing vaccines that elicit broad and lasting immune protection.

UK launches medicines scheme with £400m earmarked for clinical trials – Pharmaceutical Technology

Share this article The deal is set to come into effect at the start of 2024 and set to run until 2028. Credit: Shutterstock /

November 21, 2023

Dave Lennon’s CEO adventure goes from preclinical to commercial; GSK vet embarks on new Odyssey with Gary Glick

After stepping into the CEO post for the first time about two years ago, taking over the helm of “tissue therapeutics” startup Satellite Bio, Dave

October 7, 2023

Mainz Biomed to Showcase ColoAlert® at UEG Week 2023 in Copenhagen, Denmark – Biotech Investments

Issuer: Mainz BioMed N.V. / Key word(s): Conference 11.10.2023 / 14:01 CET/CEST The issuer is solely responsible for the content of this announcement. Mainz Biomed

October 12, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.